featured
Efficacy of PD-L1 Blockade in Combination With Carboplatin as Immune Induction in Patients With Metastatic Lobular Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Nature Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial
Nat Cancer 2023 Apr 01;4(4)535-549, L Voorwerk, OI Isaeva, HM Horlings, S Balduzzi, M Chelushkin, NAM Bakker, E Champanhet, H Garner, K Sikorska, CE Loo, I Kemper, IAM Mandjes, M de Maaker, JJL van Geel, J Boers, M de Boer, R Salgado, MGJ van Dongen, GS Sonke, KE de Visser, TN Schumacher, CU Blank, LFA Wessels, A Jager, VCG Tjan-Heijnen, CP Schröder, SC Linn, M KokFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.